DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34+ CD15- cells in early chronic-phase chronic myeloid leukemia.

about

DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34+ CD15- cells in early chronic-phase chronic myeloid leukemia.

Item

http://www.wikidata.org/entity/Q52633239

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

DNA methylation profiling reve ...... hase chronic myeloid leukemia.

@en

DNA methylation profiling reve ...... hase chronic myeloid leukemia.

@nl

type

Item

label

DNA methylation profiling reve ...... hase chronic myeloid leukemia.

@en

DNA methylation profiling reve ...... hase chronic myeloid leukemia.

@nl

prefLabel

DNA methylation profiling reve ...... hase chronic myeloid leukemia.

@en

DNA methylation profiling reve ...... hase chronic myeloid leukemia.

@nl

P1476

DNA methylation profiling reve ...... hase chronic myeloid leukemia.

@en

P2093

Agnès Guerci-Bresler

http://www.w3.org/2001/XMLSchema#string

Alexandre Janel

http://www.w3.org/2001/XMLSchema#string

Céline Bourgne

http://www.w3.org/2001/XMLSchema#string

Denis Guyotat

http://www.w3.org/2001/XMLSchema#string

Eric Hermet

http://www.w3.org/2001/XMLSchema#string

Franck Court

http://www.w3.org/2001/XMLSchema#string

Gabriel Etienne

http://www.w3.org/2001/XMLSchema#string

Hyacinthe Johnson

http://www.w3.org/2001/XMLSchema#string

Juliette Berger

http://www.w3.org/2001/XMLSchema#string

Marc G Berger

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of a melanoma antigen, PRAME, as a BCR/ABL-inducible gene

DNA Methylation Dynamics of Human Hematopoietic Stem Cell Differentiation

Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome

Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib

A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing

Aberrant DNA methylation is associated with disease progression, resistance to imatinib and shortened survival in chronic myelogenous leukemia.

SL-401 and SL-501, targeted therapeutics directed at the interleukin-3 receptor, inhibit the growth of leukaemic cells and stem cells in advanced phase chronic myeloid leukaemia.

Zap70 is essential for long-term survival of naive CD8 T cells

Genome-wide parent-of-origin DNA methylation analysis reveals the intricacies of human imprinting and suggests a germline methylation-independent mechanism of establishment.

Characterization of chronic myeloid leukemia stem cells.

P304

814-829

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/1878-0261.12191

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Philippe Arnaud

P577

2018-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29575763

http://www.w3.org/2001/XMLSchema#string

P921

chronic myeloid leukemia

DNA methylation

P932

5983208

http://www.w3.org/2001/XMLSchema#string